Point-of-Care In-vitro Diagnostics with Graphene Field Effect Transistors
Biosensing of Alzheimer’s Diseases biomarkers Biosensors based on graphene field effect transistors are promising candidates for reliable and...
Read more
Imagine a world where diagnosing Alzheimer’s Disease (AD) is as easy as taking a home pregnancy test. Thanks...
Read more
On July 8th, partners from the 2D-BioPAD and MUNASET projects, both initiatives members of the Graphene Flagship Initiative,...
Read more
Dr. Anthoula Tsolaki, a neurologist from Alzheimer Hellas, recently presented the 2D-BioPAD project during an online presentation. In...
Read more
After 20 years of research, Graphene is considered a “material of the future”, due to its remarkable (opto)electronic,...
Read more
Under the umbrella of the Graphene Flagship Initiative (GFI), projects like 2D-BioPAD come together for meetings, organised as...
Read more